145 related articles for article (PubMed ID: 23488777)
1. Preparation of calcium phosphate nanocapsules including simvastatin/deoxycholic acid assembly, and their therapeutic effect in osteoporosis model mice.
Ito T; Takemasa M; Makino K; Otsuka M
J Pharm Pharmacol; 2013 Apr; 65(4):494-502. PubMed ID: 23488777
[TBL] [Abstract][Full Text] [Related]
2. Preparation of injectable auto-forming alginate gel containing simvastatin with amorphous calcium phosphate as a controlled release medium and their therapeutic effect in osteoporosis model rat.
Ito T; Saito M; Uchino T; Senna M; Iafisco M; Prat M; Rimondini L; Otsuka M
J Mater Sci Mater Med; 2012 May; 23(5):1291-7. PubMed ID: 22391994
[TBL] [Abstract][Full Text] [Related]
3. Bone-targeted delivery of simvastatin-loaded PEG-PLGA micelles conjugated with tetracycline for osteoporosis treatment.
Xie Y; Liu C; Huang H; Huang J; Deng A; Zou P; Tan X
Drug Deliv Transl Res; 2018 Oct; 8(5):1090-1102. PubMed ID: 30027372
[TBL] [Abstract][Full Text] [Related]
4. Periostin-targeted SDSSD peptide decorated calcium phosphate nanocomposites incorporation with simvastatin for osteoporosis treatment.
Pan Z; Zhang Z; Deng X; Hu F; Jia F; Lu J; Zhang X; Yang X; Gao Y; Wang X; Cui X; Xu C; Wu Y
Nanotechnology; 2023 Dec; 35(7):. PubMed ID: 37976543
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of the controlled release of simvastatin from β-TCP macrosphere in the treatment of OVX mice.
Chou J; Ito T; Otsuka M; Ben-Nissan B; Milthorpe B
J Tissue Eng Regen Med; 2016 Mar; 10(3):E195-203. PubMed ID: 23784984
[TBL] [Abstract][Full Text] [Related]
6. Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
Samadfam R; Awori M; Bénardeau A; Bauss F; Sebokova E; Wright M; Smith SY
J Endocrinol; 2012 Feb; 212(2):179-86. PubMed ID: 22062085
[TBL] [Abstract][Full Text] [Related]
7. Application of calcium phosphate as a controlled-release device.
Ito T; Otsuka M
Biol Pharm Bull; 2013; 36(11):1676-82. PubMed ID: 24189411
[TBL] [Abstract][Full Text] [Related]
8. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats.
Du Z; Chen J; Yan F; Xiao Y
Clin Oral Implants Res; 2009 Feb; 20(2):145-50. PubMed ID: 19077150
[TBL] [Abstract][Full Text] [Related]
9. Preparation and properties of biocompatible PS-PEG/calcium phosphate nanospheres.
Wang Q; Liu P; Sun Y; Gong T; Zhu M; Sun X; Zhang Z; Duan Y
Nanotoxicology; 2015 Mar; 9(2):190-200. PubMed ID: 24787691
[TBL] [Abstract][Full Text] [Related]
10. Dissolution medium responsive simvastatin release from biodegradable apatite cements and the therapeutic effect in osteoporosis rats.
Hamada H; Ohshima H; Otsuka M
J Appl Biomater Funct Mater; 2012 Jun; 10(1):22-8. PubMed ID: 22367687
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin prodrug micelles target fracture and improve healing.
Jia Z; Zhang Y; Chen YH; Dusad A; Yuan H; Ren K; Li F; Fehringer EV; Purdue PE; Goldring SR; Daluiski A; Wang D
J Control Release; 2015 Feb; 200():23-34. PubMed ID: 25542644
[TBL] [Abstract][Full Text] [Related]
12. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC
Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612
[TBL] [Abstract][Full Text] [Related]
13. In situ fabrication of alendronate-loaded calcium phosphate microspheres: controlled release for inhibition of osteoclastogenesis.
Kim CW; Yun YP; Lee HJ; Hwang YS; Kwon IK; Lee SC
J Control Release; 2010 Oct; 147(1):45-53. PubMed ID: 20600398
[TBL] [Abstract][Full Text] [Related]
14. The ovariectomized, mature rat model of postmenopausal osteoporosis: an assessment of the bone sparing effects of curcumin.
French DL; Muir JM; Webber CE
Phytomedicine; 2008 Dec; 15(12):1069-78. PubMed ID: 18693096
[TBL] [Abstract][Full Text] [Related]
15. The Evaluation of Therapeutic Efficacy and Safety Profile of Simvastatin Prodrug Micelles in a Closed Fracture Mouse Model.
Zhang Y; Jia Z; Yuan H; Dusad A; Ren K; Wei X; Fehringer EV; Purdue PE; Daluiski A; Goldring SR; Wang D
Pharm Res; 2016 Aug; 33(8):1959-71. PubMed ID: 27164897
[TBL] [Abstract][Full Text] [Related]
16. Anabolic therapies for osteoporosis.
Uihlein AV; Leder BZ
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
[TBL] [Abstract][Full Text] [Related]
17. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.
Rejnmark L; Buus NH; Vestergaard P; Heickendorff L; Andreasen F; Larsen ML; Mosekilde L
J Bone Miner Res; 2004 May; 19(5):737-44. PubMed ID: 15068496
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin-loaded macroporous calcium phosphate cement: preparation, in vitro characterization, and evaluation of in vivo performance.
Yin H; Li YG; Si M; Li JM
J Biomed Mater Res A; 2012 Nov; 100(11):2991-3000. PubMed ID: 22700467
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin-loaded β-TCP drug delivery system induces bone formation and prevents rhabdomyolysis in OVX mice.
Chou J; Ito T; Otsuka M; Ben-Nissan B; Milthorpe B
Adv Healthc Mater; 2013 May; 2(5):678-81. PubMed ID: 23184712
[TBL] [Abstract][Full Text] [Related]
20. Topical anti-inflammatory effect of hypocholesterolaemic drugs.
Bracht L; Caparroz-Assef SM; Magon TF; Ritter AM; Cuman RK; Bersani-Amado CA
J Pharm Pharmacol; 2011 Jul; 63(7):971-5. PubMed ID: 21635264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
